FOLH1 and posterior cortical atrophy: PATRON is a pan-Canadian phase III pragmatic multi-institutional randomized trial leveraging the ability of PSMA PET to better detect early sites of metastases in patients with high risk and biochemically recurrent PCa in the real world setting.